Article Versions Notes

Bowers K, Amelse L, Bow A, Newby S, MacDonald A, Sun X, Anderson D, Dhar M. Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response. Bioengineering. 2022; 9(8):407. https://doi.org/10.3390/bioengineering9080407

Bowers, Kristin, Lisa Amelse, Austin Bow, Steven Newby, Amber MacDonald, Xiaocun Sun, David Anderson, and Madhu Dhar. 2022. "Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response" Bioengineering 9, no. 8: 407. https://doi.org/10.3390/bioengineering9080407

Bowers, K., Amelse, L., Bow, A., Newby, S., MacDonald, A., Sun, X., Anderson, D., & Dhar, M. (2022). Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response. Bioengineering, 9(8), 407. https://doi.org/10.3390/bioengineering9080407